What's in Avalo Therapeutics, Inc.'s pipeline?

Avalo Therapeutics, Inc. has 6 drugs in our index: 0 marketed, 0 filed, 0 in Phase 3, 5 in Phase 2, 1 in Phase 1.

Which companies overlap with Avalo Therapeutics, Inc.'s portfolio?

Top competitors by shared drug class: Pfizer, Huabo Biopharm Co., Ltd., Ahn-Gook Pharmaceuticals Co.,Ltd, Daewon Pharmaceutical Co., Ltd., AJU Pharm Co., Ltd..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/avalo-therapeutics-inc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Avalo Therapeutics, Inc. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Avalo Therapeutics, Inc. pipeline: 0 marketed, 0 filed, 0 Phase 3, 5 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 0 Phase 3 5 Phase 2 1 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

No leading-phase drugs tracked for this sponsor.

Therapeutic area mix

Autoimmune diseases, Oncology · 1
Diabetes · 1
unknown · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Pfizer · 3 shared drug classes
Huabo Biopharm Co., Ltd. · 2 shared drug classes
Ahn-Gook Pharmaceuticals Co.,Ltd · 2 shared drug classes
Daewon Pharmaceutical Co., Ltd. · 2 shared drug classes
AJU Pharm Co., Ltd. · 2 shared drug classes
Health Ever Bio-Tech Co., Ltd. · 2 shared drug classes
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · 2 shared drug classes
Daewoong Pharmaceutical Co. LTD. · 2 shared drug classes

Subscribe to ongoing alerts

Every new pipeline event for Avalo Therapeutics, Inc.:

Cite this brief

Drug Landscape (2026). Avalo Therapeutics, Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/avalo-therapeutics-inc. Accessed 2026-05-16.